Jashvant D Unadkat

发表

Toward a Consensus on Applying Quantitative Liquid Chromatography‐Tandem Mass Spectrometry Proteomics in Translational Pharmacology Research: A White Paper

Jill Barber, Bhagwat Prasad, Amin Rostami-Hodjegan, 2019, Clinical pharmacology and therapeutics.

Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model I: Insights into Factors that Determine Fetal Drug Exposure through Simulations and Sensitivity Analyses

Lu Gaohua, Jashvant D Unadkat, L. Gaohua, 2017, Drug Metabolism and Disposition.

Investigating the contribution of CYP2J2 to ritonavir metabolism in vitro and in vivo.

Jashvant D Unadkat, Evan D Kharasch, A. Collier, 2014, Biochemical pharmacology.

Quantitative Transporter Proteomics by Liquid Chromatography with Tandem Mass Spectrometry: Addressing Methodologic Issues of Plasma Membrane Isolation and Expression-Activity Relationship

Bhagwat Prasad, Jashvant D Unadkat, Cornelis E C A Hop, 2014, Drug Metabolism and Disposition.

HIV Protease Inhibitors Are Inhibitors but Not Substrates of the Human Breast Cancer Resistance Protein (BCRP/ABCG2)

Yi Zhang, Jashvant D Unadkat, Qingcheng Mao, 2004, Journal of Pharmacology and Experimental Therapeutics.

Interactions of azole antifungal agents with the human breast cancer resistance protein (BCRP).

Jashvant D Unadkat, Qingcheng Mao, J. Unadkat, 2007, Journal of pharmaceutical sciences.

Cytochrome P450-dependent catabolism of vitamin K: ω-hydroxylation catalyzed by human CYP4F2 and CYP4F11.

F Peter Guengerich, Bhagwat Prasad, Toshio Okano, 2013, Biochemistry.

Interindividual and Regional Variability in Drug Transporter Abundance at the Human Blood–Brain Barrier Measured by Quantitative Targeted Proteomics

Bhagwat Prasad, Yurong Lai, Jashvant D Unadkat, 2019, Clinical pharmacology and therapeutics.

In Vitro-to-in Vivo Prediction of P-glycoprotein-Based Drug Interactions at the Human and Rodent Blood-Brain Barrier

Jashvant D Unadkat, Rodney J Y Ho, R. Ho, 2008, Drug Metabolism and Disposition.

Drug interactions at the blood-brain barrier: fact or fantasy?

Sara Eyal, Jashvant D Unadkat, J. Unadkat, 2009, Pharmacology & therapeutics.

Expansion of a PBPK model to predict disposition in pregnant women of drugs cleared via multiple CYP enzymes, including CYP2B6, CYP2C9 and CYP2C19.

Ping Zhao, Amin Rostami-Hodjegan, Jashvant D Unadkat, 2014, British journal of clinical pharmacology.

Placental drug transporters.

Jashvant D Unadkat, A. Dahlin, J. Unadkat, 2004, Current drug metabolism.

Regulation of BCRP/ABCG2 expression by progesterone and 17beta-estradiol in human placental BeWo cells.

Yi Zhang, Honggang Wang, Jashvant D Unadkat, 2006, American journal of physiology. Endocrinology and metabolism.

Modulation of P-glycoprotein at the Human Blood-Brain Barrier by Quinidine or Rifampin Treatment: A Positron Emission Tomography Imaging Study

David A Mankoff, Janet F Eary, Jashvant D Unadkat, 2015, Drug Metabolism and Disposition.

The role of transporters in drug interactions.

Christopher J Endres, Jashvant D Unadkat, C. Endres, 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model II: Verification of the Model for Passive Placental Permeability Drugs

Jashvant D Unadkat, J. Unadkat, Zufei Zhang, 2017, Drug Metabolism and Disposition.